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Abstract 
 
Objectives:  
The data presented here is part of a study that was aimed at characterizing the molecular mechanisms 
of polyunsaturated fatty acid metabolism by CYP2J2, the main cytochrome P450 enzyme active in the 
human cardiovasculature. This part comprises the molecular dynamics simulations of the binding of 
three eicosanoid substrates to wild type and mutant forms of the enzyme. These simulations were 
carried out with the aim of dissecting the importance of individual residues in the active site and the 
roles they might play in dictating the binding and catalytic specificity exhibited by CYP2J2.  
 
Data description:  
The data comprise: a) a new homology model of CYP2J2, b) a number of predicted low-energy 
complexes of CYP2J2 with arachidonic acid, docosahexaenoic acid and eicosapentaenoic acid, produced 
with molecular docking and c) a series of molecular dynamics simulations of the wild type and four 
mutants interacting with arachidonic acid as well as simulations of the wild type interacting with the two 
other eicosanoid ligands. The simulations may be helpful in identifying the determinants of substrate 
specificity of this enzyme and in unraveling the role of individual mutations on its function. They may 
also help guide the generation of mutants with altered substrate preferences. 
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Objective 
The polyunsaturated fatty acids (PUFAs) arachidonic acid (AA), docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA) are oxidised by cytochrome P450 (CYP) enzymes to produce metabolically 
active products that play significant roles in inflammation pathways [1][2]. Due to the absence of a 
crystal structure of the main such enzyme in the human cardiovasculature (CYP2J2), the precise 
mechanism by which it metabolises PUFAs into specific stereo- and regio-epoxyisomers is not fully 
understood. Consequently, the effect of mutations in the protein sequence arising from non-
synonymous single nucleotide polymorphisms found in the population cannot be predicted, hindering 
our ability to link genomic information to dysregulation of inflammatory responses and thus successful 
prognoses of cardiovascular health. In this project, we aimed to understand binding of PUFAs in the 
active site of CYP2J2 using computational methods and leverage this information to investigate the 
residues essential for ligand positioning and metabolism. In previous work, our groups investigated the 
interaction of AA with human CYP2J2 and revealed Arg117 as a key player in the recognition of this 
substrate [3], although these simulations were relatively short (50 ns). Simulations from other studies 
have come to diverse conclusions about the role of individual residues in the active site [4–6]. Here, we 
tried to investigate further using much more extensive simulations of both wild type and mutant forms 
of the enzyme. These new simulations confirmed the importance of Arg117 but in addition suggested 
Arg111 as a residue necessary for epoxidation and pointed to the role of two more arginine residues in 
the active site that allow some redundancy in substrate tethering and contribute to the flexibility of the 
catalytic capabilities of the system. Expression trials in HEK293T cells to produce CYP2J2 and its mutants 
were unsuccessful so the computationally derived hypotheses could not be validated in the lifetime of 
this project.  
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Data description 
 
Table 1: Overview of data files/data sets. 
Label Name of data file/data set  File types  
(file extension) 
Data repository and identifier (DOI 
or accession number) 
Data set 1: 
Homology modelling, 
molecular docking 
and molecular 
dynamics 
simulations of wild 
type and mutant 
human CYP2J2 with 
three 
polyunsaturated 
fatty acids 
 
Abelak_etal_Methods.pdf 
 
C2J2_min3_mod_noH.pdb 
 
create_sim4_repeats.sh 
 
docking_wildtype_C2J2.zip 
 
PDF document  
 
PDB file (.pdb) 
 
Shell script (.sh) 
 
Zipped file of 9 
pdb files (.zip) 
 
Zenodo  
DOI: 10.5281/zenodo.3465884 
Data set 2: 
Molecular dynamics 
simulations of the 
interaction of wild 
type human CYP2J2 
with arachidonic acid 
 
MD_wt_CYP2J2_AA_StateX_rep
eatY.zip 
(X = pose number, 1<=X<=6; 
Y=repeat number, 1<=Y<=4) 
Zipped files 
(.zip)  
Zenodo 
Poses 1 and 2: 
DOI: 10.5281/zenodo.3465590 
 
Poses 3 and 4 
DOI: 10.5281/zenodo.3466692 
 
Poses 5 and 6 
DOI: 10.5281/zenodo.3473886 
Data set 3: 
Molecular dynamics 
simulations of the 
interaction of wild 
type human CYP2J2 
with DHA (POSES 1-
4) 
MD_wt_CYP2J2_DHA_StateX_r
epeatY.zip  
 
(X = pose number, 1<=X<=4; 
Y=repeat number, 1<=Y<=3) 
Zipped files 
(.zip)  
Zenodo 
DOI: 10.5281/zenodo.3473909 
Data set 4: 
Molecular dynamics 
simulations of the 
interaction of wild 
type human CYP2J2 
with EPA (POSES 1-4) 
MD_wt_CYP2J2_EPA_StateX_re
peatY.zip 
 
(X = pose number, 1<=X<=4; 
Y=repeat number, 1<=Y<=3) 
Zipped files 
(.zip)  
Zenodo 
DOI: 10.5281/zenodo.3473927 
Data set 5: 
Molecular dynamics 
simulations of the 
interaction of 
mutant human 
CYP2J2 (R111A) with 
MD_mutR111A_CYP2J2_AA_Sta
teX_repeatY.zip 
 
(X = pose number, 1<=X<=6; 
Y=repeat number, 1<=Y<=3) 
Zipped files 
(.zip)  
Zenodo 
Poses 1-3: 
DOI: 10.5281/zenodo.3483594 
 
Poses 4-6: 
DOI: 10.5281/zenodo.3483966 
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arachidonic acid 
Data set 6: 
Molecular dynamics 
simulations of the 
interaction of 
mutant human 
CYP2J2 (R117A) with 
arachidonic acid 
MD_mutR117A_CYP2J2_AA_Sta
teX_repeatY.zip 
 
(X = pose number, 1<=X<=6; 
Y=repeat number, 1<=Y<=3) 
  
Zipped files 
(.zip), 
Zenodo 
Poses 1-4: 
DOI: 10.5281/zenodo.3482943 
 
Poses 5-6: 
DOI: 10.5281/zenodo.3483493 
Data set 7: 
Molecular dynamics 
simulations of the 
interaction of double 
mutant human 
CYP2J2 (R111A, 
R117A) with 
arachidonic acid 
MD_mutR111A_R117A_CYP2J2
_AA_StateX_repeatY.zip  
(X = pose number, 1<=X<=6; 
Y=repeat number, 1<=Y<=3) 
 
Zipped files 
(.zip)  
Zenodo 
Poses 1-3: 
DOI: 10.5281/zenodo.3484029 
 
Poses 4-6: 
DOI: 10.5281/zenodo.3484124 
Data set 8: 
Molecular dynamics 
simulations of the 
interaction of 
quadruple mutant 
human CYP2J2 
(R111A, R117A, 
R382A, R446A) with 
arachidonic acid 
MD_quadmut_CYP2J2_AA_Stat
eX_repeatY.zip 
 
(X = pose number, 1<=X<=6; 
Y=repeat number, 1<=Y<=3) 
  
Zipped files 
(.zip)  
Zenodo 
Poses 1-3: 
DOI: 10.5281/zenodo.3484437 
 
Poses 4-6: 
DOI: 10.5281/zenodo.3484448 
  
The data presented here comprise the results of homology modeling of the human wild type CYP2J2 and 
generation of models for a series of mutants [7]; molecular docking of three eicosanoid ligands (AA, DHA 
and EPA) to wild type CYP2J2 [7]; finally, a series of molecular dynamics simulations of the wild type and 
mutant enzyme with the three ligands [8–20]. Below is a brief description of each part of the data. More 
details are available in the Methods document on the top Zenodo repository [7]. 
 
Homology model of CYP2J2 
The homology model [7] is based on the UniProt [21] protein sequence with UID P51589. A model of the 
sequence with the N-terminal transmembrane domain (residues 1-43) trimmed was built using 
MODELLER version 9.14 [22], using as templates the PDB structures: 1SUO [23], 2P85 [24], 3EBS [25] and 
1Z10 [26]. A haem molecule was incorporated into the model building using the HETATM records from 
PDB structure 1SUO.  
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Structure models of mutants of CYP2J2 were produced using the homology model of the wild type 
enzyme as the starting point and changing residues 111, 117, 382 and 446 from arginine to alanine. The 
expectation was that mutating these residues to a non-charged amino acid would have a noticeable 
impact on the binding of fatty acid substrates. 
 
Docking of PUFAs to CYP2J2 
The fatty acids arachidonic acid (AA), docosahexaenoic acid  (DHA) and eicosapentaenoic acid (EPA) 
were investigated in this study. The structure of AA was obtained from the Zinc Dock database version 
12 [27]. Structures for DHA and EPA were derived using the Automated Topology Builder version 2.2 
[28] . Docking of all ligands to CYP2J2 models was carried out using Autodock VINA version 1.1.2 [29]. 
Five independent docking runs were carried out for each ligand. 
 
Molecular Dynamics simulations  
MD simulations were carried out using AMBER14 [30] as described in the Methods document (data set 1 
[7]). The simulations included the standard minimization, heating, equilibration and production phases. 
Six docked wild type CYP2J2-AA complexes were simulated in four independent runs, each lasting 1μs 
[8–10]. Simulations of the mutant enzymes started from the same six docked poses of AA but each pose 
was simulated in three repeats, each lasting 500 ns. Two single mutants were investigated (Arg111Ala 
[13, 14], Arg117Ala [15, 16]) followed by a double mutant (Arg111Ala and Arg117Ala [17, 18]) and finally 
a quadruple mutant (Arg111Ala, Arg117Ala, Arg382Ala and Arg446Ala [19, 20]). Simulations of DHA [12] 
and EPA [11] were carried out starting from four docked poses, each simulation repeated three times 
and lasting 300 ns.  
The simulations highlighted two residues in the active site (Arg111 and Arg117) that appear to play 
important roles in anchoring the carboxylate group of the substrate. Simulations also suggested that 
mutating any one of these two residues, results in enhancing the role of the other one as a hydrogen-
bond donor, and that if both are mutated, two more arginine residues (Arg382 and Arg446) can partially 
make up for the missing charged groups in the active site.  
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Limitations  
As with all computational studies, the data here should be interpreted with care. The starting CYP2J2 
structure used in these simulations is a homology model, i.e. a structure built in silico using information 
from related proteins whose structures have been deposited in the PDB. Although we have built the 
model using an alignment of multiple, carefully selected structures, it is possible that inaccuracies in the 
initial structure have affected the final simulations. Our molecular dynamics simulations (ranging from 
900ns to 4μs) are, to the best of our knowledge, the longest carried out on human CYP2J2 and, in 
addition, multiple repeats using the same starting docked pose of the ligand were used to assess the 
robustness of observations to differences introduced by the random nature of the algorithm. Despite 
the length of these simulations and the evidence pointing to reasonable convergence in energy terms, 
simulations appeared to sample different conformations of the system, even when the same starting 
pose was used (in different repeats). These MD runs thus point towards a very flexible system that is 
better described as an ensemble of possible states, whose probability is affected by the substrate nature 
or mutations in the active site. Longer simulation times would have been useful in revealing whether 
convergence of the system to a few distinct conformations is possible, given enough simulation time. 
The haem molecule plays an important role in these simulations. Haem was modeled here in its penta-
coordinated high-spin ferric form but the alternative highly reactive iron-oxygen species complex should 
be considered too. Finally, modeling a restricted part of this system around the haem molecule using a 
quantum mechanical (QM) model would be advisable.  A joint QM/MM system could be setup that 
would offer a more realistic representation of how the intermediate complex between haem and 
substrate is formed. 
 
Abbreviations 
AA: arachidonic acid 
CYP: cytochrome P450 
DHA: docosahexaenoic acid 
EPA: eicosapentaenoic acid 
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MD: molecular dynamics 
MM: molecular mechanics 
PDB: Protein Data Bank 
PUFA: polyunsaturated fatty acid 
QM: quantum mechanical 
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